Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma
- 1 August 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (2) , 332-339
- https://doi.org/10.1016/s0168-8278(99)80232-3
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hematogenous Spreading of Hepatocellular Carcinoma Cells: Possible Participation in Recurrence in the LiverHepatology, 1997
- Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular CarcinomaAnnals of Surgery, 1995
- Liver transplantation for hepatocellular carcinoma.Gut, 1995
- Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinomaHepatology, 1994
- Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.American Journal of Roentgenology, 1993
- Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosisHepatology, 1990
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989
- Early recognition of hepatocellular carcinomaHepatology, 1986
- Screening Methods for Early Detection of Hepatocellular CarcinomaHepatology, 1985
- Role of Liver Transplantation in Cancer TherapyAnnals of Surgery, 1985